Source: Eur Respir Monogr 2019; 83: 140-157
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Kian Fan Chung, Gary B. Huffnagle, Yvonne J. Huang. The lung microbiome in obstructive airways disease: potential pathogenetic roles. Eur Respir Monogr 2019; 83: 140-157

Member's Comments

No comment yet.

Related content which might interest you: What are the common biological mechanisms that lead to obstructive airway disease? Source: International Congress 2016 – Early life origins of asthma and COPD Year: 2016 The role of cluster analysis in defining phenotypes of obstructive airway diseases: is there a need for a new taxonomy of obstructive airway diseases? Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD Year: 2011 The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 The link between inflammation and lung cancer: lessons from chronic obstructive pulmonary disease Source: International Congress 2018 – Scientific Year in Review Year: 2018 Multiple inflammatory hits and the pathogenesis of severe airway disease Source: Eur Respir J 2006; 27: 884-888 Year: 2006 Investigation of the role of miRNAs as a biomarker in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - COPD inflammation and genes Year: 2012 Bacterial load in chronic obstructive pulmonary disease and its relationship with airway inflammation and lung function Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 The role of inflamatory markers in obstructive pulmonary disease Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care Year: 2012 Defining airflow limitation and chronic obstructive pulmonary disease: the role of outcome studies Source: Eur Respir J 2015; 46: 8-10 Year: 2015 Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Understanding the different physiology behind breathlessness due to obstructive and restrictive lung diseases Source: Annual Congress 2009 - PG10 Self management in chronic respiratory disease Year: 2009 Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure Source: Eur Respir Rev, 30 (162) 210077; 10.1183/16000617.0077-2021 Year: 2021 Possible mechanisms underlying the development of cachexia in COPD Source: Eur Respir J 2008; 31: 492-501 Year: 2008 Systemic inflammation: a link between chronic obstructive pulmonary disease and lung cancer? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Mucus production in chronic obstructive lung diseases: relationship with infections Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases Year: 2006 Current perspectives in epithelial cell injury and repair: consequences for epithelial functions Source: Eur Respir Rev 2005; 14: 126-130 Year: 2005 The role of the tracheal phonography in chronic obstructive lung disease and asthma diagnosis Source: Annual Congress 2012 - Asthma management Year: 2012 Host–microbe interactions in distal airways: relevance to chronic airway diseases Source: Eur Respir Rev 2015; 24: 78-91 Year: 2015